Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction in Patients With Paroxysmal Atrial Fibrillation: The COFFEE-AF Trial

NCT05464940 is registered in ClinicalTrials.gov with Kansas City Heart Rhythm Research Foundation as lead sponsor.

NCT NCT05464940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05464940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction in Patients With Paroxysmal Atrial Fibrillation: The COFFEE-AF Trial
Lead sponsor
Kansas City Heart Rhythm Research Foundation
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
June 30, 2026
Enrollment
100 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation